Cargando…
Tracking fibrosis in myeloproliferative neoplasms by CCR2 expression on CD34(+) cells
In myeloproliferative neoplasm (MPNs), bone marrow fibrosis - mainly driven by the neoplastic megakaryocytic clone - dictates a more severe disease stage with dismal prognosis and higher risk of leukemic evolution. Therefore, accurate patient allocation into different disease categories and timely i...
Autores principales: | Pozzi, Giulia, Carubbi, Cecilia, Gobbi, Giuliana, Tagliaferri, Sara, Mirandola, Prisco, Vitale, Marco, Masselli, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444005/ https://www.ncbi.nlm.nih.gov/pubmed/36072806 http://dx.doi.org/10.3389/fonc.2022.980379 |
Ejemplares similares
-
Cytokine Profiling in Myeloproliferative Neoplasms: Overview on Phenotype Correlation, Outcome Prediction, and Role of Genetic Variants
por: Masselli, Elena, et al.
Publicado: (2020) -
The Genetic Makeup of Myeloproliferative Neoplasms: Role of Germline Variants in Defining Disease Risk, Phenotypic Diversity and Outcome
por: Masselli, Elena, et al.
Publicado: (2021) -
ROS in Platelet Biology: Functional Aspects and Methodological Insights
por: Masselli, Elena, et al.
Publicado: (2020) -
Buffering Adaptive Immunity by Hydrogen Sulfide
por: Pozzi, Giulia, et al.
Publicado: (2022) -
Evolution led humans to bipedalism, but we live in a sedentary society: Will “Sunday running” protect us from NCDs at no cost?
por: Presta, Valentina, et al.
Publicado: (2023)